Health Condition 1: E08-E13- Diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Indian adults who are 18 years and above 2) Individuals with type 2 diabetes 3) Individuals who are currently on or would be soon put on the Continuous Glucose Monitoring System
Exclusion criteria
Exclusion criteria: 1) Pregnant women or breastfeeding women 2) Severe liver dysfunction, which presented as alanine transaminase or aspartate transaminase exceeding three times the upper limit of the normal range 3) Severe kidney dysfunction, which is defined as creatinine exceeding two times the upper limit of the normal range or estimated glomerular filtration rate (eGFR) less than 30 ml/min/1.73 m2 4) Moderate-Severe anemia: Haemoglobin not greater than 109 g/L (10.9g/dL) in men and women (15 years and above) as per the WHO Recommendations 5) Presently suffering from any infectious diseases such as Covid-19 (SARS-CoV-2), tuberculosis, etc 6) Participation in another ongoing clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of nutrient and energy intake as well as diet quality on Glycemic Control by assessing the Mean Glucose and Glycosylated hemoglobin A1C (HbA1C)Timepoint: Mean Glucose: 3 days Glycosylated hemoglobin A1C (HbA1C): previous 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of meal frequency and timings, physical activity, sleep quality on glycemic variabilityTimepoint: 3 days sleep quality: past month | — |
Countries
India
Contacts
Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Womens University